Introduction
============

The brown planthopper (BPH), *Nilaparvata lugens* (Stål) (Hemiptera: Delphacidae), is a classic pesticide-induced resurgence insect pest. The fungicide jinggangmycin (JGM), a product of *Streptomyces var. jinggangen*, is applied for rice sheath blight (*Rhizoctonia solani*) control in China ([@B29]). JGM foliar sprays alter BPH male and female physiological parameters and enhance fecundity, by up to 99%. A few examples of these physiological changes include enhanced flight capacity, thermotolerance, body weights, protein and lipid contents, and JH titers ([@B18]). It is an attractive product due to its low cost, efficacy in the field, low toxicity and environmental residue. The current concern is that it also has real potential to spark agroecological catastrophes that may follow JGM-stimulated BPH fecundity.

JGM increased BPH fecundity via increased fatty acid metabolism ([@B19]; [@B22]), however, the broad impact of JGM led us to consider additional pathways that might also influence BPH reproduction. From digital gene (DEG) expression profiles, we identified a UDP-glycosyltransferase 1-2 like (*UGT12*) gene that was up-regulated in adult females following foliar JGM treatments (200 ppm) at 2 days after emergence (2 DAE). The UGTs form a superfamily of enzymes that catalyze the transfer of a glycosyl group from a nucleotide sugar, such as UDP-glucuronic acid or UDP-glucose, to a variety of small hydrophobic molecules (aglycones), thereby making them hydrophilic for efficient excretion ([@B26]; [@B28]; [@B27]). Members of this superfamily are ubiquitous and act in many biological processes, including olfaction ([@B21]), steroid metabolism, and detoxification of exogenous substrates ([@B28]).

In insects, these enzymes typically utilize UDP-glucose as the sugar donor ([@B1]). As in vertebrates, endogenous and exogenous substrates undergo glycosylation in insects. Insect UGTs act in detoxification of plant allelochemicals, cuticle formation, pigmentation, olfaction, and ecdysteroid (20E) metabolism ([@B35]; [@B16]; [@B1],[@B2]; [@B37]). The UGT enzyme activity has been reported in tissues, such as fat body, of many insect orders, including fruit flies, *Drosophila melanogaster* (Diptera: Drosophilidae) ([@B30]). The presence of UGT enzymes in the antenna of *D. melanogaster* indicate a role in olfaction ([@B37]). UGT activity was also recorded in silkworms, *Bombyx mori* (Lepidoptera: Bombycidae) ([@B25]). Many endogenous compounds, like 20E ([@B33]) and cuticle tanning precursors ([@B16]; [@B3]) are glycosylated by UGTs. UGTs in *Helicoverpa armigera* Hübner (Lepidoptera: Noctuidae) are factors for host plant adaptation and insecticide resistance ([@B15]). [@B22] found that *UGT2B17* operates in chlorantraniliprole resistance in *Plutella xylostella* (L.) (Lepidoptera: Plutellidae).

It remains unknown whether UGT-encoding genes act in insect reproduction, although they may act indirectly. [@B8], for example, reported that UGT1a genes are expressed in murine placentas and fetal livers in a model of intracytoplasmic sperm injection and *in vitro* fertilization. These genes promote enhanced steroid hormone clearance, which may mediate negative outcomes. In their review of the UGT superfamily, [@B27] note that UGT-encoding genes are expressed in a range of reproduction-functioning tissues, including ovary, uterus, cervix, placenta, breast, testes, and prostate. We infer UGTs influence reproductive events by catalyzing various metabolic steps that influence levels of steroid hormones and other biomolecules. From this, we posed the hypothesis that NlUGT12 acts as a positive modulator of BPH reproductive biology. In this paper we report on the outcomes of experiments designed to test our hypothesis.

Materials and Methods {#s1}
=====================

Rice Variety, Insect, and Pesticide
-----------------------------------

Rice seeds (*Oryza sativa* L.) of the variety Ningjing 2 (Japonica rice) were sown in rectangular field cement tanks (200 cm × 100 cm × 60 cm, L, W, H). Rice plants at the tillering stage were used for all experiments.

The *Nilaparvata lugens* strain was obtained from the China National Rice Research Institute (CNRRI: Hangzhou, China). BPH were reared on rice plants in cement tanks covered with fine mesh under natural conditions from April to October and thereafter overwintered in an insectary at 26 ± 2°C and 14L:10D at Yangzhou University. Technical grade JGM (C~20~H~35~O~13~N) (61.7% a.i) (Qianjing Biochemistry Co. Ltd., Haining, Zhejiang Province, China) was used in all trials. Third instar BPH was used in all experiments ([@B13]; [@B36]).

Experimental Design
-------------------

Rice plants were sprayed with 200 ppm JGM and control plants were treated with tap water. Each treatment was repeated three times (3 pots) and distributed randomly. The 72 h-post-spray nymphs were selected for RNAi experiments and maintained in a climate chamber (Model: RXZ 328A) (Jiangnan Instrument Factory, Ningbo, Zhejiang, China) at 26 ± 2°C and L16:D8 in glass jars (6-cm diameter, 12-cm height) with a rice stem until emergence.

dsRNA Synthesis
---------------

Based on our digital gene (DEG) expression profiles, we selected UGT12 (accession no. XM022331295) as a RNAi target in the JGM-treated BPH. To synthesize double-stranded RNA (dsRNA), a 575 bp (the fragment from 861 to 1435 bp) was amplified with T~7~ RNA polymerase promoter linked primers ([Table 1](#T1){ref-type="table"}). The thermocycler (T-100, Bio-Rad Co., California, United States) was programmed at pre-denaturing at 94°C for 4 min, followed by 35 cycles of denaturing at 94°C for 30 s, annealing at 55.2°C for 30 s and extension at 72°C for 1 min, with a final extension at 72°C for 10 min. The products were sequenced and then used as queries in BLAST searches to control identity in NCBI (98--99% identity) prior to dsRNA synthesis. The GFP gene (accession no. ACY56286) was used as a negative control ([@B7]). All dsRNAs were synthesized using a T~7~ RiboMAX^TM^ Express RNAi System (Promega, Madison, WI, United States) according to the manufacturer's protocols. The dsRNA products were diluted with 50 μL diethylpyrocarbonate-treated water and stored at -80°C. The purified dsRNAs were quantified using spectroscopy at 260 nm and separated by agarose gels to validate their integrity.

###### 

PCR primers used in this study.

  Purpose         Primer ID   Sequence (5′-3′)                         Size (bp)
  --------------- ----------- ---------------------------------------- -----------
  qPCR analysis   Q-UGT12-F   ACACTGCCTACGAACTGGAA                     157
                  Q-UGT12-R   CTCCATCCTCTGACTCGTCC                     
                  Q-Vg-F      GCTTGTCAGAATGCCACC                       184
                  Q-Vg-R      TCTTGCCAGAAGGATTGC                       
                  Q-VgR-F     AGGCAGCCACACAGATAACCGC                   136
                  Q-VgR-R     AGCCGCTCGCTCCAGAACATT                    
                  Q-JHAMT-F   AAATACGGCAATAAGAAC                       112
                  Q-JHAMT-R   GAAGACAATAAAACGAGA                       
                  Q-Met-F     CCGCACCCAACAACAATACA                     288
                  Q-Met-R     CCAATCCGTTTACCACCACA                     
                  actin-F     TGCGTGACATCAAGGAGAAGC                    186
                  actin-R     CCATACCCAAGAAGGAAGGCT                    
  dsRNA           UGT12-F     GGACGAGTCAGAGGATGGAG                     575
  synthesis       UGT12-R     AGGTGAGATCAAAGCAGGCT                     
                  UGT12-T7F   Taatacgactcactataggg (T~7~ promoter)     
                              GGACGAGTCAGAGGATGGAG                     
                  UGT12-T7R   Taatacgactcactataggg (T~7~ promoter)     
                              AGGTGAGATCAAAGCAGGCT                     
                  GFP-F       AAGGGCGAGGAGCTGTTCACCG                   688
                  GFP-R       CAGCAGGACCATGTGATCGCGC                   
                  GFP-T7F     Taatacgactcactataggg (T~7~ promoter)     
                              AAGGGCGAGGAGCTGTTCACCG                   
                  GFP-T7R     Taatacgactcactataggg (T~7~ protometer)   
                              CAGCAGGACCATGTGATCGCGC                   
                                                                       

F, forward; R, reverse. Lowercase letters labeled sequences represent for T

7

promoter.

Silencing UGT12
---------------

BPH were released into potted rice and treated with JGM as just described. The dsRNA treatments induced high mortality of second instar nymphs (over 95%) ([@B12]). Third-instar nymphs (20/treatment) were collected 3 days after the JGM treatments, and subjected to RNAi via an artificial diet as described by [@B9], with slight modifications. Earlier studies found a high efficiency of dsRNA ingestion-mediated gene silencing in BPH ([@B11]). Glass cylinders (15.0-cm L × 2.5-cm D) have been used as feeding chambers, with four dsRNA concentrations, 0.12, 0.075, 0.05, and 0.025 μg/μL. In this study, the optimal dsRNA concentration, 0.075 μg/μL, was determined from preliminary experiments with the noted concentrations. The artificial diet (40 μL) was held between two layers of stretched Parafilm M membrane enclosing the two open ends of the chamber (the diet capsule), which was replaced every second day. Six days later, fifth (final) instar nymphs were transferred into a glass jar (12-cm H × 6-cm D), and maintained on rice plants under 26 ± 2°C, RH 90%, and 16L:8D photoperiod. The newly emerged females were collected separately and soluble protein content (fat body and ovary, 15 BPH/replicate or *n* = 15, *N* = 3 replicates), JH (whole body, *n* = 5, *N* = 3) and ecdysone titers (whole body, *n* = 5, *N* = 3), body weight (*n* = 10, *N* = 3), and longevity (*N* = 19) were recorded. We used whole bodies to determine the expression levels of *NlVg*, *NlVgR* (vitellogenin receptor, VgR), *NlJHAMT*, *NlMet*, and *NlUGT12* (*n* = 5, *N* = 3 for each gene) at 2 or 3 DAE and similarly whole bodies were used to determine Vg, JHAMT, Met, and UGT12. All the replicates were biologically independent. We separately selected 3 groups, 10 virgin females/group, to determine *NlUGT12* RNAi efficiency at 1, 3, 5, and 7 DAE. Others were used to isolate reproductive tracts at 2, 4, and 6 DAE. We recorded the pre-oviposition period, oviposition period, adult female longevity, and fecundity of 20 mated pairs (untreated ♀ × ♂). The eggs laid were counted under a microscope and rice stalks were replaced every second day.

Extraction and cDNA Synthesis
-----------------------------

Total RNA was extracted using the Trizol reagent (Invitrogen, Carlsbad, CA, United States) according to the manufacturer's instructions. The concentration and purity of RNA sample were measured using a Nanodrop 2000C spectrophotometer (Thermo Fisher Scientific, West Palm Beach, FL, United States) and the integrity was checked by 1.5% agarose gel electrophoresis. Genomic DNA was cleared bussing DNase treatment. The first-strand cDNA was synthesized from 1 μg of the total RNA using a PrimeScript RT Reagent Kit with gDNA Eraser (TaKaRa, Tokyo, Japan) in a final volume of 20 μL.

Quantitative Real-Time PCR (qPCR)
---------------------------------

Primers for qPCR were designed at <http://primer3.ut.ee/> ([@B31]) ([Table 1](#T1){ref-type="table"}). Primer sets were validated by relative standard curves for each gene transcript and amplification efficiency (*E*) along with correlation coefficient (*R^2^*) were calculated for each primer pair. All qPCR reactions were performed in biologically independent triplicates in a CFX96 real-time PCR system (Bio-Rad Co., Ltd., California, United States). Each 10 μL reaction contained 5 μL 2 × SYBR Premix^EX^ TaqII Master Mix (TaKaRa, Tokyo, Japan), 0.4 μL reverse primer (10 μM), 1 μL cDNA template and 3.2 μL of deionized water. The thermocycler was programmed at 95°C for 30 s, followed by 35 cycles at 95°C for 5 s, 55.2°C for 15 s, and 72°C for 1 min. A β-actin (EU179846) cDNA fragment was amplified with actin-F and actin-R primers ([Table 1](#T1){ref-type="table"}) as a reference gene ([@B7]). The relative mRNA levels of target genes were quantified using the 2^-ΔΔCt^ method ([@B23]). Three biologically independent replicates based on independent RNA sample preparations were performed for each gene.

Effects of Dietary dsRNA on Biological Performance Parameters
-------------------------------------------------------------

Protein contents in the fat bodies and ovaries were determined using the Bradford protocol ([@B6]; [@B14]) with Coomassie Brilliant Blue G 250 (Shanghai Chemical Agent Co., Ltd., Shanghai, China). The fat bodies and ovaries were isolated under a zoom-stereomicroscope (model XTL20, Beijing Tech Instrument Co., Ltd., Beijing, China) in a cooled petri dish. The isolated ovaries and fat bodies were placed in pre-weighed separate ice-cold centrifuge tubes. The tubes were re-weighted on a Mettler-Toledo electronic balance (EC 100 model; 1/10000 g sensitivity), homogenized on ice in 5 mL phosphate buffered saline (PBS; 137 nM NaCl; 2.68 nM KCl; 1.47 mM KH~2~PO~4~; and 8.10 mM Na~2~HPO~4~, pH 7.0), and centrifuged at 10,000 × g at 4°C for 20 min. The supernatants were collected as sample preparations. A standard curve was established based on a standard protein (bovine serum albumin (Shanghai Biochemistry Research Institute, Shanghai, China). The absorbance at 595 nm was determined in a UV755B spectrometer (Shanghai Precision Instrument Co., Ltd., Shanghai, China). The protein content in the sample solution was calculated from the standard curve.

For body weight measurement, 10 females at 2 DAE were used as a replicate for each treatment, and control group. Females were placed in pre-weighed centrifuge tubes and weighed on the balance just described. The treatment and control groups had three biologically independent replicates.

We followed the manufacturer's instructions to determine JH III (*n* = 5, *N* = 3) and ecdysone titers (*n* = 5, *N* = 3) of whole body using an insect double sandwich ELISA kit (Qiaodu biological technology Co., Ltd., Shanghai, China). Each treatment was performed in biologically independent triplicates.

Hormone Treatment
-----------------

Methoprene (Sigma Chemical Co., Ltd.,cn, United States, weight, 100 mg, Purity, 99.5%) was dissolved in 1 mL acetone to produce a 100 μg/μL stock solution, and stored at -20°C ([@B5]). The stock solutions were diluted to concentrations indicated in Results with acetone and topically applied to the backs of newly emerged, RNAi-treated (100 ng/μL) females using a syringe (Terumo), and a micro applicator (Burkard). The BPH were transferred into glass jars described above and maintained on rice plants at 26 ± 2°C, RH 90%, and 16L:8D photoperiod. The insects were collected at 24 and 48 h, and *NlVg* and *NlUGT12* expression levels, and Vg protein synthesis post methoprene administration were determined. Each treatment was performed in biologically independent triplicates.

Ovary Isolation
---------------

The ovaries were isolated from the 2, 4, and 6 DAE females. There were four treatment groups: untreated controls, JGM-treated, JGM+dsGFP-treated, and JGM+dsUGT12-treated in 1 × PBS, *n* = at least 10 ovaries/group. After extensive washing, ovaries were photographed with a Leica DMR connected to a Fuji FinePix S~2~ Pro digital camera (Germany).

Western Blot Analysis
---------------------

Isolated fat bodies were homogenized in precooled lysis buffer (8 M urea, 4% CHAPS, 40 nM Tris pH 8.0, 5 nM EDTA, 1 mM PMSF, and 10 mM DTT) (Amersco, Solon, OH, United States) and 0.2 mM protease inhibitor (Roche Diagnostics, Basel, Switzerland), held at 4°C for 1 h and centrifuged at 12,000 ×*g* at 4°C for 20 min. Protein concentration was detected using a bicinchoninic acid (BCA) method (CWOO14S, CWBIO Biological Co., Taizhou, Jiangsu Province, China). Aliquots of 30 μg protein were separated by 8% SDS-PAGE, electroblotted (Model: 1658001, Bio-Rad, Co., Ltd., California, United States) onto polyvinglidene fluoride membrane (PVDF) (Millipore, Billerica, MA, United States). After blocking with 5% non-fat milk (Amersco, Solon, OH, United States) in Tris--buffered saline (TBS) for 2 h at room temperature, the membranes were incubated with *N. lugens* primary antibodies for *β-actin* (1:2000) and *NlVg* (1:5000) at 4°C overnight. After washing three times for 15 min each with 0.5% Tween-20 in TBS (TBST), the membranes were incubated with goat anti-rabbit immunoglobulin G horseradish peroxidase-conjugated secondary antibody (Sigma, St. Louis, MO, United States) for 1 h at room temperature ([@B24]). The immunoreactivity was detected using the SuperSignal West Pico Chemiluminescent Substrate ECL (Pierce, Rockford, IL, United States) and the membrane was imaged with a GBOX-Chemi XT4 Imager (Syngene, Cambridge, United Kingdom). Vg protein abundance was compared with the internal control, β-actin. The Vg antibody was a gift from Professor Qiang Zhou (Sun Yat-sen University). The mean gray values of each band were normalized to β-actin using NIH image J software^[1](#fn01){ref-type="fn"}^, *n* = 3 biologically independent replicates ([Supplementary Material](#SM1){ref-type="supplementary-material"}).

Population Growth
-----------------

We set up four mating groups: 1/ controls, untreated males × untreated females; 2/ control-♂ × JGM-treated females (JGM-♀); 3/ control-♂ × JGM+dsGFP-treated females (JGM+dsGFP-♀); and 4/ control-♂ × JGM+dsUGT12-treated females (JGM+dsUGT12-♀). The experiment was arranged with a randomized complete block design with five biologically independent replicates. Two pairs of newly emerged BPH were released onto rice plants and covered with an 80-mesh nylon cylindrical cage (20 cm D × 80 cm H) in each pot. Ten days later, we started counting the next generation neonates each day, which were transferred into new plastic plots with rice plants covered as described until the parent females died. Numbers of neonates in the new plastic plot were recorded every second day until adult emergence. Numbers of unhatched eggs on the rice stems were recorded. Hatching rate was also recoded (total neonates/total neonates plus unhatched eggs). The population growth index (PGI) was expressed as N1/N0, with N1 representing the total neonates of next generation and unhatched eggs, and N0 representing the insects released (N0 = 4).

Statistical Analysis
--------------------

The normal distributions and homogeneity of variances (determined using the Bartlett test) were verified before performing analysis of variance (ANOVA) tests. A one-way ANOVA was performed for the number of eggs laid (*N* = 19), the pre-oviposition period (*N* = 19), the oviposition period (*N* = 19), the longevity of the females (*N* = 19), the contents of soluble protein (fat body and ovary, *n* = 15, *N* = 3), JH III and ecdysone titer (*n* = 5, *N* = 3), body weight (*n* = 10, *N* = 3), longevity (*N* = 19), the number of offspring (*N* = 5), hatching rate (*N* = 5), gender ratio (*N* = 5), western blot (*n* = 20, *N* = 3), and *NlVg, NlVgR, NlJHAMT, NlMet* and *NlUGT12* expression levels (*n* = 5, *N* = 3). All data were expressed as means ± standard error of the mean (SEM) from three independent biological replicates, unless otherwise noted in figure legends. Two-way (days after emergence and dsRNA treatment) ANOVAs were performed to analyze the data in [Figure 1](#F1){ref-type="fig"}. Multiple comparisons of the means were conducted using Fisher's Protected Significant Difference (PLSD) test. All analyses were conducted using the data processing system (DPS) of [@B34]. Biological parameter data were analyzed using an analysis of variance (ANOVA) with one factor and statistical data are presented in [Table 2](#T2){ref-type="table"}.

![Effects of JGM+dsUGT12 treatments on expression levels at different days post emergence (DAE). *NlUGT12* expression value of untreated females was converted to 1. The histogram bars show mean relative gene expression (*n* = 3 independent biological replicates) and the error bars represent one standard deviation (Tukey, *P* \< 0.05). Gene expression was normalized to the β-actin reference gene.](fphys-10-00747-g001){#F1}

###### 

Statistical analyses of biological parameter data.

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Experiment                                                                                 Statistic
  ------------------------------------------------------------------------------------------ ----------------------------------------------------
  dsUGT12 reduced *NlUGT12* expression at different days after emergence                     *F* = 1030.8, df = 3, 47, *P* = 0.0001

  Effects of dsUGT12 silencing on *NlUGT12* expression at DAEs                               *F* = 1.4, df = 3, 47, *P* = 0.2552

  Effects of dsUGT12 silencing on interactive effect between DAEs and JGM+dsRNA treatments   *F* = 8.8, df = 3, 47, *P* = 0.0001

  dsUGT12 reduced JH titer, 2 DAE                                                            *F* = 34.2, df = 3, 11, *P* = 0.0001

  dsUGT12 increased 20E titer, 2 DAE                                                         *F* = 130.6, df = 3, 11, *P* = 0.0001

  dsUGT12 reduced protein content of fat body and ovary, 2 DAE                               *F* = 36.9, df = 3, 11, *P* = 0.0001 for fat body\
                                                                                             *F* = 21.4, df = 3, 11, *P* = 0.0004 for ovary

  dsUGT12 reduced *JHAMT* and *Met* expression, 2 DAE                                        *F* = 325.3, df = 3.11, *P* = 0.0001 for *JHAMT*\
                                                                                             *F* = 75.4, df = 3, 11, *P* = 0.0001 for *Met*

  dsUGT12 reduced body weight, 2 DAE                                                         *F* = 30.1, df = 3, 11, *P* = 0.0001

  dsUGT12 reduced number of laid eggs                                                        *F* = 39.3, df = 3, 75, *P* = 0.0001

  dsUGT12 reduced oviposition period                                                         *F* = 23.5, df = 3, 75, *P* = 0.0001

  dsUGT12 was not significant difference for preoviposition period                           *F* = 2.1, df = 3, 75, *P* = 0.1077

  dsUGT12 was not significant difference for longevity of females                            *F* = 0.659, df = 3, 75, *P* = 0.5802

  dsUGT12 reduced *NlVg* expression, 2DAE                                                    *F* = 74.6, df = 3, 11, *P* = 0.0001

  dsUGT12 reduced *NlVg* expression, 3 DAE                                                   *F* = 23.5, df = 3, 11, *P* = 0.0003

  dsUGT12 reduced *NlVgR* expression, 2 DAE                                                  *F* = 16.3, df = 3, 11, *P* = 0.0009

  dsUGT12 reduced *NlVgR* expression, 3 DAE                                                  *F* = 27.9, df = 3, 11, *P* = 0.0001

  dsUGT12+methoprene rescued *NlUGT12* expression, 24 h                                      *F* = 59.2, df = 4, 14, *P* = 0.0001

  dsUGT12+methoprene rescued *NlUGT12* expression, 48 h                                      *F* = 99.8, df = 4, 14, *P* = 0.0001

  dsUGT12+methoprene rescued *NlVg* expression, 24 h                                         *F* = 39.6, df = 4,14, *P* = 0.0001

  dsUGT12+methoprene rescued *NlVg* expression, 48 h                                         F = 66.5, df = 4, 14, *P* = 0.0001

  dsUGT12 reduced number of offspring                                                        *F* = 16.9, df = 3, 19, *P* = 0.0001

  dsUGT12 reduced eggs hatching rate                                                         *F* = 18.6, df = 3, 19, *P* = 0.0001

  dsUGT12 let to no significant difference for gender ratio                                  *F* = 1.62, df = 3, 19, *P* = 0.1847
  -----------------------------------------------------------------------------------------------------------------------------------------------

Results
=======

dsUGT12 Treatments Reduce JGM-Enhanced NlUGT12 Expression
---------------------------------------------------------

Compared to untreated controls, the JGM treatments led to substantially increased accumulations of mRNA encoding NlUGT12 over the 7-day experiment. The dsUGT12 treatments reversed the enhancing influence of JGM, with accumulations of NlUG12-encoding mRNA below control levels except for day 7 (down from the JGM influence by 39--53%) ([Figure 1](#F1){ref-type="fig"}). The pattern did not differ across days (all statistics are listed in [Table 3](#T3){ref-type="table"}). We recorded an interactive effect between DAE and JGM+dsRNA treatments.

###### 

Influence of JGM+dsUGT12 treatment on the number of offspring, hatching rate, and gender ratio.

  Treatments    Number of eggs laid   Hatching rate   Gender ratio    PGI (N1/N0)
  ------------- --------------------- --------------- --------------- -------------
  Control       386.0 ± 25.7b         0.91 ± 0.03a    1.44 ± 0.42ab   96.5
  JGM           516.6 ± 56.2a         0.95 ± 0.02a    1.92 ± 0.41a    129.2
  JGM+dsGFP     534.8 ± 97.3a         0.94 ± 0.02a    2.02 ± 0.46a    113.7
  JGM+dsUGT12   286.4 ± 54.2c         0.83 ± 0.05b    1.65 ± 0.55ab   71.6

∗

Means ± SE of five replicates. Means with columns followed by different letters are significantly different at the 5% level (p \< 0.05, Tukey test). Control Group, control-♀ × control-♂; JGM Group, JGM-♀ × control-♂; JGM+dsGFP Group, JGM+dsGFP-♀ × control-♂; JGM+dsUGT12 Group, JGM+dsUGT12-♀ × control-♂.

dsUGT12 Treatments Alter Protein Contents and Related Parameters in JGM-Treated BPH
-----------------------------------------------------------------------------------

Compared to controls, the JGM treatments led to substantially increased fat body and ovarian proteins, JH III titer, accumulations of mRNA encoding JHAMT and Met, and body weights. The treatments led to reduced 20E titers. None of the treatments influenced adult female lifespans ([Figure 2](#F2){ref-type="fig"}). dsUGT12 treatment in nymphs effectively reversed the positive influences of JGM. In general, the dsUGT12 treatment yielded values not different from untreated controls, with the exception of *JHAMT* expression ([Figure 2E](#F2){ref-type="fig"}) with results slightly but significantly lower than control results.

![Effects of JGM+dsUGT12 treatments on female physiology at 2 DAE. For all panels, unless noted differently, *n* = 3 independent biological replicates. **(A)** The histogram bars show mean fat body soluble protein content (μg/female,±SE) at 2 DAE. **(B)** The histogram bars show mean ovarian soluble protein content (μg/female). **(C)** the histogram bars show mean JH III titer (ng/L) in adult females (*n* = 3). **(D)** The histogram bars show mean ecdysone titer (ng/L) in adult female. **(E)** The histogram bars show mean *JHAMT* mRNA relative expression level. **(F)** The histogram bars show mean *Met* mRNA relative expression level. **(G)** The histogram bars show mean body weight (mg/10 females). **(H)** The histogram bars show mean longevity of adult females (*n* = 19 independent biological replicates).](fphys-10-00747-g002){#F2}

dsUGT12 Treatments Reduce Egg Deposition in JGM-Treated BPH
-----------------------------------------------------------

Untreated control BPH deposited about 370 eggs/female, which was substantially increased in the JGM-treated group. The dsUGT12 treatment led to reduced egg laying in JGM-treated BPHs, significantly below results with untreated controls ([Figure 3A](#F3){ref-type="fig"}). JGM treatments had no influence on the pre-oviposition period ([Figure 3B](#F3){ref-type="fig"}) although the treatments led to significant increase in oviposition period, which was reversed by the dsUGT12 treatment ([Figure 3C](#F3){ref-type="fig"}).

![Effects of JGM+dsUGT12 treatment on adult females reproduction parameters. **(A)** The histogram bars show mean numbers of eggs laid (*n* = 19 independent biological replicates). **(B)** The histogram bars show pre-oviposition period (days) (*n* = 19 independent biological replicates). **(C)** The histogram bars show oviposition period (days) (*n* = 19 independent biological replicates).](fphys-10-00747-g003){#F3}

dsUGT12 Treatments Led to Dysfunctional Ovaries in JGM-Treated BPH
------------------------------------------------------------------

dsUGT12 treatment ([Figure 4D,H,L](#F4){ref-type="fig"}) impeded ovarian development compared to JGM-treatments ([Figure 4B,C,F,G,J,K](#F4){ref-type="fig"}) at 2, 4, and 6 DAE. The ovarioles of JGM-treated groups contained two or more banana--shaped oocytes ([Figure 4B](#F4){ref-type="fig"}) at 2 DAE while there were no such oocytes in untreated controls, nor in the JGM+dsUGT12-treated group during the same time period ([Figure 4A,D](#F4){ref-type="fig"}). Ovaries of the untreated control group ([Figure 4A,E,I](#F4){ref-type="fig"}), the JGM-treated group ([Figure 4B,F,J](#F4){ref-type="fig"}), and JGM+dsGFP group ([Figure 4C,G,K](#F4){ref-type="fig"}) contained mature eggs (light brown colored) at 4 and 6 DAE, but the JGM+dsUGT12-treated group contained no mature eggs ([Figure 4H,L](#F4){ref-type="fig"}).

![Effects of JGM+dsUGT12 on female reproductive tract at 2, 4, and 6 DAE. The third instar nymphs amenable to JGM spraying were treated with dsUGT12 diet. **(A--L)** reproductive tracts were dissected from mated females and photographed. Ovaries from at least ten females of each group were dissected and observed under a microscope. Scale bar, 200 μm.](fphys-10-00747-g004){#F4}

dsUGT12 Treatments Reversed the Enhancing Influence of JGM on *NlVg* Expression and Vg Synthesis
------------------------------------------------------------------------------------------------

Jinggangmycin treatments led to increased accumulations of mRNAs encoding NlVg and NlVgR relative to the controls. The dsUGT12 treatments reversed the enhancing influence of JGM at 2 DAE and 3 DAE ([Figure 5A,B](#F5){ref-type="fig"}). We recorded similar results with *NlVgR* at 2 and 3 DAE ([Figure 5C,D](#F5){ref-type="fig"}). With respect to Vg protein contents, dsUGT12 treatment overcame the JGM-induced results ([Figure 5E](#F5){ref-type="fig"}). Western blot analysis yielded similar results ([Figure 5F](#F5){ref-type="fig"} and [Supplementary Figure S1](#SM1){ref-type="supplementary-material"}).

![Effects of JGM+dsUGT12 treatment on *NlVg, NlVgR* expression and Vg protein synthesis. **(A**,**B)** The histogram bars show mean *NlVg* expression level at 2 DAE and 3 DAE, respectively. **(C**,**D)** The histogram bars show mean *NlVgR* expression level at 2 DAE and 3 DAE. **(E)** The histogram bars show mean gray values of each band at 2 DAE. **(F)** Effects of JGM+dsUGT12-treated on protein levels of Vg in the fat body of adult females at 2 DAE. Western blot analysis was performed using Vg antibody specific for *N. lugnes*.](fphys-10-00747-g005){#F5}

Methoprene Application Rescues *NlUGT12* Expression and Vg Synthesis
--------------------------------------------------------------------

Jinggangmycin led to increased accumulations of mRNA encoding NlUGT12 which, again, were reversed by the dsUGT12 treatments. Topical methoprene application onto newly emerged adult females partially rescued *NlUGT12* expression in the dsUGT12-treated group at 24 h ([Figure 6A](#F6){ref-type="fig"}) and 48 h post treatment ([Figure 6B](#F6){ref-type="fig"}). Methoprene applications similarly rescued *NlVg* expression ([Figure 7A,B](#F7){ref-type="fig"}) and Vg contents ([Figure 7C,D](#F7){ref-type="fig"}). Western blot analysis yielded similar results ([Figure 7E,F](#F7){ref-type="fig"} and [Supplementary Figure S2](#SM1){ref-type="supplementary-material"}).

![Effects of methoprene topical application on *NlUGT12* expression level. **(A)** The histogram bars show *NlUGT12* expression level at 24 h post administered (^∗∗^ denotes significant difference at *P* \< 0.01). **(B)** The histogram bars showed *NlUGT12* expression level at 48 h post administered (The asterisk represents significant difference at *P* \< 0.05).](fphys-10-00747-g006){#F6}

![Effects of methoprene topical application on *NlVg* expression and Vg protein expression levels. The histogram bars show *NlVg* expression level at 24 h **(A)** and 48 h **(B)** (^∗∗^ denotes significant difference at *P* \< 0.01). The histogram bars show mean gray values of Vg protein levels at 24 h **(C)** and 48 h **(D)** (^∗∗^ denotes significant difference at *P* \< 0.01). The Vg protein levels of JGM+dsUGT12-treated female fat bodies was quantified 24 h **(E)** and 48 h **(F)** post methoprene topical application relative to the other groups which received the equivalent amount of acetone.](fphys-10-00747-g007){#F7}

dsUGT12 Treatment Led to Reduced Egg Laying and Hatch Rates
-----------------------------------------------------------

Compared to untreated controls, JGM treatments significantly increased the number of eggs laid (by 34%), gender ratio (by 33%), and PGI (by 34%). dsUGT12 treatments led to reduced numbers of deposited eggs (by 45%) and egg hatching rates (by 13%), gender ratio (by 14%), and PGI (by 45%) in the JGM+dsUGT12 treated group compare to JGM treated group ([Table 2](#T2){ref-type="table"}). dsGFP treatments had no effect on JGM-enhanced egg deposition ([Table 2](#T2){ref-type="table"}). None of the treatments influenced the BPH gender ratios.

Discussion
==========

The results presented in this paper strongly support our hypothesis that *NlUGT12* is a positive modulator of BPH reproductive biology. Several points are germane to the point. First, JGM treatments led to increased fat body and ovarian protein contents, increased JHIII titers, decreased 20E titers, increased JHAMT and Met expression, increased body weights, increased egg deposition and duration of the oviposition period, elevated expression of *Nlvg* and *NlvgR* and production of Vg protein, and elevated *UGT12* expression. Second, a dsRNA construct specific to NlUGT12 effectively reversed the JGM enhanced influence. Third, JH analog methoprene treatment partially rescued dsUGT12 effect. We infer that *NlUGT12* acts via its cognate protein NlUGT12, as a positive modulator of BPH reproduction.

Overall, our results tend to show that NlUGT12 modulates fecundity and population growth in *N. lugens*, probably by regulating JH and Vg synthesis. Indeed, JGM is a very broadly-applied treatment for rice sheath blight (*R. solani*) control in China ([@B29]). These treatments lead to increased egg deposition. Because egg development is mediated by JH, we considered the possibility that the JGM effect on reproduction acts through JH. JGM exposure leads to increased JH, but not 20E, titers and to increases in mRNA encoding two JH-related proteins, JHAMT and the JH receptor, Met. JHAMT acts at the final step in converting inactive precursors into active JH and increases in JHAMT expression is consistent with increased JH titers. Similarly, increases in Met expression are consistent with enhancing the physiological functioning of JH. 20E titers were decreased under JGM exposure, from which we infer the JGM effects are focused on reproductive, rather than developmental events. Most results indicate that suppressing *NlUGT12* expression reverses the enhancing influences of JGM. We considered the possibility of a direct connection between *NlUGT12* and JH actions, from which we determined the reversing influence of a JH analog, methoprene, on dsRNA-mediated *NlUGT12* suppression.

Insect eggs reflect heavy resource investments, particularly proteins. Increased amounts of fat body protein are consistent with increased Vg synthesis, transport, and receptor-mediated ovarian uptake, a necessary foundation of increased egg laying. The increased protein supports increased egg production and deposition, which is seen, also, in higher numbers of deposited eggs. These JGM-mediated increases may be seen in increased body weights, particularly in females. We determined the influence of JGM on oviposition periods because insect egg-laying processes take time. Although it varies according to the rice developmental stage, BPHs typically lay eggs in groups, in rows usually in rice sheaths but also on leaves. We recorded increased oviposition periods, which is consistent with increased egg deposition. We considered egg hatch rates as an indicator of egg quality, which was not influenced by JGM.

UDP-glucuronosyltransferases act in multiple processes, including detoxification of ingested plant allelochemicals and inactivation of steroid hormones ([@B1]; [@B20]; [@B4]). Phylogenetic analysis ([@B17]) indicates the closest relatives of baculovirus EGT are the UGT33 and UGT34 families of lepidopteran UGTs. Baculoviral EGT disrupts the hormonal balance of insect hosts by catalyzing the inactivating conjugation of 20Es with a sugar moiety from UDP-glucose or UDP-galactose ([@B10]), which leads to abnormal larval growth ([@B32]; [@B17]). Because UPDs act in 20E metabolism, we infer that *NlUGT12* positively modulates reproduction and the JGM-driven increases in reproduction via influencing developmental hormone titers.

The idea that NlUGT12 acts via influencing hormone titers is strongly supported by our findings. Silencing *NlUGT12* led to diminished JH III titers and increased 20E titers, relative to the outcomes of JGM and JGM+dsGFP treatments, from which we infer that NlUGT12 directly influences developmental hormone titers. mRNAs encoding JHAMT, which acts in JH biosynthesis and Met, the receptor responsible for JH actions, were diminished in BPHs following dsNlUGT12 treatments, again, supporting our view of *NlUGT12* as a central player in BPH hormonal homeostasis. The *Vg* and *VgR* directly act in insect fecundity. Their synthesis, transport and uptake are regulated mainly by JHs and, again, dsUGT12 treatments in JGM treated group led to reduced JH titers, which reduces *Vg* and *VgR* expression and subsequent ovarian Vg uptake. We infer that NlUGT12 exerts its actions via developmental hormones.

Topically applied methoprene, a JH analog, reversed the influences of the JGM+dsUGT12 treatments on *NlUGT12* and *NlVg* expression, and on Vg synthesis. Our interpretation is that *NlUGT12* influences JH synthesis, which regulates *NlVg* expression and Vg protein synthesis. The reduced protein contents of fat bodies and ovaries in JGM+dsUGT12-treated females may preclude synthesis of yolk protein from vitellogenin, accompanied by restricted ovarian development and reproduction.
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